Wandercraft published its first case study of the Atalante X self-balancing exoskeleton in a long-term care setting, in Kinésithérapie, la Revue. A 31-year-old woman with spastic quadriparesis due to cerebral palsy completed 36 weekly sessions at Résidence Terro Flourido in Avignon, improving her walking distance (6MWT) by 58% and her FIM score from 69 to 104, with no adverse events reported.
Wandercraft announced that its self-balancing exoskeleton Atalante X has received FDA clearance for rehabilitation training in patients with spinal cord injuries at levels T5 to L5, its second FDA clearance following approval for stroke rehabilitation in December 2022. The clearance is based on safety and efficacy data from more than 500 patients, including clinical trials and real-world evidence; Atalante X features powered ankle joint mechanisms and self-balancing technology, allowing patients to stand, walk, and step in different directions during their first training session.
Elite Robots has passed the MTBF 100,000-hour evaluation and certification by SEPRI, which it calls the longest mean time between failures test in the industry to date. The validation focused on the CS series collaborative robots, which use an integrated design of harmonic reducer, motor, and output feedback shaft, offer IP68 protection across the entire series, and feature modular brakes that passed more than 100,000 category-1 emergency stop tests and more than 10,000 category-0 emergency stop tests. The company has a 3,000㎡ production workshop and a 100,000-class 2,500㎡ clean joint assembly workshop, with annual capacity exceeding 5,000 units.